An	O
integrative	O
approach	O
to	O
characterize	O
disease	O
-	O
specific	O
pathways	O
and	O
their	O
coordination	O
:	O
a	O
case	O
study	O
in	O
cancer	B-DS

Background	O

The	O
most	O
common	O
application	O
of	O
microarray	O
technology	O
in	O
disease	O
research	O
is	O
to	O
identify	O
genes	O
differentially	O
expressed	O
in	O
disease	O
versus	O
normal	O
tissues	O
.	O

However	O
,	O
it	O
is	O
known	O
that	O
,	O
in	O
complex	O
diseases	O
,	O
phenotypes	O
are	O
determined	O
not	O
only	O
by	O
genes	O
,	O
but	O
also	O
by	O
the	O
underlying	O
structure	O
of	O
genetic	O
networks	O
.	O

Often	O
,	O
it	O
is	O
the	O
interaction	O
of	O
many	O
genes	O
that	O
causes	O
phenotypic	O
variations	O
.	O

Results	O

In	O
this	O
work	O
,	O
using	O
cancer	B-DS
as	O
an	O
example	O
,	O
we	O
develop	O
graph	O
-	O
based	O
methods	O
to	O
integrate	O
multiple	O
microarray	O
datasets	O
to	O
discover	O
disease	O
-	O
related	O
co	O
-	O
expression	O
network	O
modules	O
.	O

We	O
propose	O
an	O
unsupervised	O
method	O
that	O
take	O
into	O
account	O
both	O
co	O
-	O
expression	O
dynamics	O
and	O
network	O
topological	O
information	O
to	O
simultaneously	O
infer	O
network	O
modules	O
and	O
phenotype	O
conditions	O
in	O
which	O
they	O
are	O
activated	O
or	O
de	O
-	O
activated	O
.	O

Using	O
our	O
method	O
,	O
we	O
have	O
discovered	O
network	O
modules	O
specific	O
to	O
cancer	B-DS
or	O
subtypes	O
of	O
cancers	B-DS
.	O

Many	O
of	O
these	O
modules	O
are	O
consistent	O
with	O
or	O
supported	O
by	O
their	O
functional	O
annotations	O
or	O
their	O
previously	O
known	O
involvement	O
in	O
cancer	B-DS
.	O

In	O
particular	O
,	O
we	O
identified	O
a	O
module	O
that	O
is	O
predominately	O
activated	O
in	O
breast	B-DS
cancer	I-DS
and	O
is	O
involved	O
in	O
tumor	B-DS
suppression	O
.	O

While	O
individual	O
components	O
of	O
this	O
module	O
have	O
been	O
suggested	O
to	O
be	O
associated	O
with	O
tumor	B-DS
suppression	O
,	O
their	O
coordinated	O
function	O
has	O
never	O
been	O
elucidated	O
.	O

Here	O
by	O
adopting	O
a	O
network	O
perspective	O
,	O
we	O
have	O
identified	O
their	O
interrelationships	O
and	O
,	O
particularly	O
,	O
a	O
hub	O
gene	O
PDGFRL	B-GP
that	O
may	O
play	O
an	O
important	O
role	O
in	O
this	O
tumor	B-DS
suppressor	O
network	O
.	O

Conclusion	O

Using	O
a	O
network	O
-	O
based	O
approach	O
,	O
our	O
method	O
provides	O
new	O
insights	O
into	O
the	O
complex	O
cellular	O
mechanisms	O
that	O
characterize	O
cancer	B-DS
and	O
cancer	B-DS
subtypes	O
.	O

By	O
incorporating	O
co	O
-	O
expression	O
dynamics	O
information	O
,	O
our	O
approach	O
can	O
not	O
only	O
extract	O
more	O
functionally	O
homogeneous	O
modules	O
than	O
those	O
based	O
solely	O
on	O
network	O
topology	O
,	O
but	O
also	O
reveal	O
pathway	O
coordination	O
beyond	O
co	O
-	O
expression	O
.	O

Introduction	O

The	O
recent	O
development	O
of	O
microarray	O
technology	O
has	O
significantly	O
facilitated	O
the	O
identification	O
of	O
disease	O
-	O
related	O
genes	O
[	O
1	O
-	O
4	O
].	O

However	O
,	O
many	O
disease	O
phenotypes	O
are	O
determined	O
not	O
by	O
individual	O
genes	O
,	O
but	O
by	O
the	O
coordinated	O
effect	O
of	O
many	O
genes	O
.	O

Insight	O
into	O
the	O
structure	O
and	O
coordination	O
of	O
disease	O
-	O
related	O
pathways	O
is	O
crucial	O
to	O
understanding	O
the	O
pathophysiology	O
of	O
complex	O
diseases	O
.	O

However	O
,	O
it	O
has	O
proved	O
difficult	O
to	O
infer	O
pathways	O
from	O
microarray	O
data	O
by	O
deriving	O
modules	O
of	O
multiple	O
related	O
genes	O
,	O
rather	O
than	O
individual	O
genes	O
.	O

The	O
major	O
challenges	O
are	O
:	O
(	O
1	O
)	O
Genes	O
involved	O
in	O
a	O
pathway	O
may	O
exhibit	O
complex	O
expression	O
relationships	O
beyond	O
co	O
-	O
expression	O
,	O
which	O
may	O
be	O
overlooked	O
by	O
standard	O
microarray	O
analysis	O
methods	O
such	O
as	O
clustering	O
[	O
5	O
].	O

(	O
2	O
)	O
Pathways	O
are	O
dynamic	O
and	O
the	O
current	O
static	O
annotation	O
of	O
pathways	O
may	O
not	O
serve	O
as	O
a	O
good	O
template	O
.	O

In	O
fact	O
,	O
pathways	O
are	O
manual	O
dissections	O
of	O
the	O
underlying	O
dynamic	O
gene	O
regulatory	O
network	O
.	O

Under	O
different	O
conditions	O
,	O
different	O
segments	O
of	O
the	O
ensemble	O
network	O
will	O
be	O
activated	O
,	O
leading	O
to	O
condition	O
-	O
specific	O
activation	O
of	O
pathways	O
[	O
6	O
].	O

In	O
this	O
study	O
,	O
by	O
integrating	O
many	O
microarray	O
datasets	O
we	O
propose	O
a	O
novel	O
method	O
to	O
simultaneously	O
infer	O
pathways	O
and	O
disease	O
/	O
phenotypic	O
conditions	O
under	O
which	O
the	O
pathways	O
are	O
activated	O
.	O

The	O
identified	O
pathways	O
may	O
comprise	O
genes	O
with	O
complex	O
expression	O
relationships	O
beyond	O
co	O
-	O
expression	O
.	O

Due	O
to	O
the	O
existence	O
of	O
a	O
large	O
amount	O
of	O
cancer	B-DS
microarray	O
data	O
,	O
we	O
used	O
cancer	B-DS
as	O
our	O
case	O
study	O
.	O

We	O
collected	O
a	O
series	O
of	O
microarray	O
datasets	O
measuring	O
different	O
types	O
of	O
cancers	B-DS
,	O
and	O
a	O
series	O
of	O
datasets	O
measuring	O
other	O
cellular	O
/	O
physiological	O
conditions	O
.	O

We	O
first	O
construct	O
a	O
differential	O
co	O
-	O
expression	O
network	O
,	O
in	O
which	O
each	O
node	O
represents	O
a	O
gene	O
and	O
each	O
edge	O
indicates	O
a	O
gene	O
pair	O
that	O
is	O
frequently	O
co	O
-	O
expressed	O
in	O
cancer	B-DS
datasets	O
but	O
not	O
in	O
non	O
-	O
cancer	B-DS
datasets	O
.	O

We	O
then	O
dissect	O
the	O
networks	O
into	O
cancer	B-DS
-	O
subtype	O
specific	O
network	O
modules	O
by	O
considering	O
(	O
1	O
)	O
co	O
-	O
expression	O
dynamics	O
and	O
(	O
2	O
)	O
network	O
topology	O
.	O

Figure	O
1a	O
illustrates	O
the	O
conceptual	O
pipeline	O
of	O
our	O
method	O
.	O

Overview	O
of	O
analysis	O
procedure	O
.	O

(	O
A	O
)	O
Flow	O
chart	O
of	O
the	O
analysis	O
pipeline	O
.	O

(	O
B	O
)	O
Schematic	O
illustration	O
of	O
the	O
concept	O
of	O
second	O
-	O
order	O
similarity	O
.	O

It	O
is	O
obvious	O
that	O
the	O
overall	O
expression	O
similarity	O
between	O
the	O
two	O
gene	O
pairs	O
(	O
genes	O
1	O
and	O
2	O
versus	O
genes	O
3	O
and	O
4	O
)	O
is	O
not	O
significantly	O
high	O
,	O
but	O
their	O
first	O
-	O
order	O
expression	O
correlation	O
profiles	O
exhibit	O
high	O
second	O
-	O
order	O
similarity	O
.	O

(	O
C	O
)	O
Schematic	O
illustration	O
of	O
the	O
dissection	O
of	O
differential	O
co	O
-	O
expression	O
networks	O
into	O
network	O
modules	O
based	O
on	O
the	O
co	O
-	O
expression	O
dynamics	O
and	O
network	O
connectivity	O
.	O

In	O
the	O
heat	O
map	O
,	O
every	O
column	O
corresponds	O
to	O
a	O
dataset	O
and	O
every	O
row	O
corresponds	O
to	O
a	O
gene	O
pair	O
.	O

Red	O
,	O
black	O
,	O
green	O
and	O
grey	O
corresponds	O
to	O
positive	O
,	O
low	O
,	O
negative	O
and	O
missing	O
correlations	O
,	O
respectively	O
.	O

By	O
hierarchical	O
clustering	O
,	O
the	O
gene	O
pairs	O
fall	O
into	O
two	O
major	O
second	O
-	O
order	O
clusters	O
.	O

The	O
9	O
gene	O
pairs	O
in	O
the	O
green	O
cluster	O
comprise	O
three	O
connected	O
network	O
components	O
,	O
whereas	O
the	O
6	O
gene	O
pairs	O
in	O
the	O
red	O
cluster	O
give	O
rise	O
to	O
three	O
connected	O
components	O
.	O

Furthermore	O
,	O
by	O
considering	O
the	O
second	O
order	O
cluster	O
of	O
a	O
higher	O
level	O
of	O
the	O
hierarchy	O
,	O
which	O
consists	O
of	O
both	O
green	O
and	O
red	O
clusters	O
,	O
the	O
six	O
networks	O
are	O
united	O
to	O
form	O
two	O
connected	O
networks	O
,	O
reflecting	O
the	O
hierarchical	O
modularity	O
of	O
cancer	B-DS
co	O
-	O
expression	O
networks	O
.	O

To	O
measure	O
co	O
-	O
expression	O
dynamics	O
,	O
we	O
use	O
second	O
-	O
order	O
expression	O
similarity	O
,	O
which	O
we	O
proposed	O
previously	O
[	O
5	O
].	O

Briefly	O
,	O
if	O
we	O
define	O
first	O
-	O
order	O
expression	O
similarity	O
as	O
the	O
expression	O
similarity	O
of	O
two	O
genes	O
from	O
one	O
dataset	O
,	O
then	O
second	O
-	O
order	O
similarity	O
measures	O
whether	O
two	O
gene	O
pairs	O
simultaneously	O
exhibit	O
either	O
high	O
or	O
low	O
expression	O
similarity	O
across	O
multiple	O
datasets	O
.	O

In	O
general	O
,	O
high	O
first	O
-	O
order	O
similarity	O
suggests	O
the	O
existence	O
of	O
a	O
functional	O
link	O
between	O
two	O
genes	O
,	O
and	O
clustering	O
based	O
on	O
the	O
second	O
-	O
order	O
similarity	O
captures	O
multiple	O
functional	O
links	O
always	O
activated	O
and	O
deactivated	O
under	O
similar	O
conditions	O
.	O

Such	O
functional	O
links	O
are	O
likely	O
to	O
comprise	O
a	O
functional	O
module	O
.	O

Interestingly	O
,	O
genes	O
in	O
a	O
second	O
-	O
order	O
cluster	O
may	O
not	O
always	O
have	O
high	O
first	O
-	O
order	O
similarity	O
(	O
see	O
an	O
example	O
in	O
Figure	O
1b	O
);	O
therefore	O
,	O
second	O
-	O
order	O
analysis	O
allows	O
us	O
to	O
identify	O
functional	O
modules	O
that	O
are	O
inaccessible	O
to	O
co	O
-	O
expression	O
analysis	O
.	O

Given	O
multiple	O
gene	O
pairs	O
sharing	O
high	O
second	O
-	O
order	O
similarity	O
,	O
we	O
further	O
divide	O
them	O
into	O
network	O
components	O
based	O
on	O
their	O
connectivity	O
on	O
the	O
differential	O
co	O
-	O
expression	O
graph	O
(	O
see	O
an	O
example	O
in	O
Figure	O
1c	O
).	O

We	O
observe	O
that	O
genes	O
within	O
a	O
connected	O
network	O
component	O
are	O
more	O
likely	O
to	O
participate	O
in	O
the	O
same	O
specific	O
pathway	O
than	O
those	O
between	O
different	O
components	O
(	O
see	O
Supplementary	O
document	O
in	O
Additional	O
file	O
1	O
),	O
which	O
,	O
in	O
turn	O
,	O
are	O
likely	O
to	O
be	O
involved	O
in	O
different	O
relevant	O
pathways	O
.	O

This	O
may	O
reveal	O
high	O
-	O
order	O
cross	O
-	O
pathway	O
coordination	O
.	O

In	O
fact	O
,	O
hierarchical	O
clustering	O
of	O
differentially	O
co	O
-	O
expressed	O
gene	O
pairs	O
based	O
on	O
their	O
second	O
-	O
order	O
similarity	O
results	O
in	O
a	O
hierarchical	O
modularity	O
in	O
terms	O
of	O
relevance	O
of	O
functional	O
links	O
.	O

We	O
designed	O
a	O
linear	O
scaling	O
model	O
to	O
select	O
modules	O
by	O
considering	O
both	O
module	O
size	O
(	O
number	O
of	O
edges	O
)	O
and	O
within	O
-	O
module	O
second	O
-	O
order	O
similarity	O
.	O

Then	O
,	O
given	O
selected	O
modules	O
,	O
we	O
can	O
further	O
infer	O
datasets	O
(	O
phenotypic	O
conditions	O
)	O
in	O
which	O
a	O
module	O
is	O
activated	O
,	O
i	O
.	O
e	O
.	O
in	O
which	O
genes	O
in	O
the	O
module	O
coordinate	O
.	O

Applying	O
our	O
methods	O
to	O
32	O
cancer	B-DS
-	O
related	O
microarray	O
datasets	O
,	O
and	O
23	O
non	O
-	O
cancer	B-DS
related	O
datasets	O
,	O
we	O
derived	O
162	O
second	O
-	O
order	O
clusters	O
consisting	O
of	O
224	O
network	O
modules	O
,	O
activated	O
either	O
in	O
cancer	B-DS
or	O
in	O
specific	O
cancer	B-DS
subtypes	O
.	O

In	O
particular	O
,	O
we	O
identified	O
a	O
breast	B-DS
cancer	I-DS
specific	O
network	O
module	O
that	O
involved	O
in	O
tumor	B-DS
suppression	O
via	O
platelet	B-GP
-	I-GP
derived	I-GP
growth	I-GP
factor	I-GP
(	O
PDGF	B-GP
)-	O
like	O
signaling	O
,	O
more	O
importantly	O
,	O
a	O
hub	O
gene	O
PDGFRL	B-GP
that	O
may	O
play	O
an	O
important	O
role	O
in	O
this	O
tumor	B-DS
suppressor	O
module	O
.	O

Results	O

Network	O
properties	O
of	O
the	O
cancer	B-DS
differential	O
co	O
-	O
expression	O
network	O

We	O
curated	O
32	O
human	B-OG
microarray	O
datasets	O
(	O
1	O
,	O
764	O
expression	O
profiles	O
in	O
total	O
)	O
measuring	O
cancers	B-DS
of	O
12	O
tissues	O
,	O
and	O
23	O
datasets	O
(	O
1	O
,	O
158	O
expression	O
profiles	O
)	O
not	O
related	O
to	O
cancer	B-DS
(	O
e	O
.	O
g	O
.	O
normal	O
tissues	O
,	O
chronic	B-DS
granulomatous	I-DS
disease	I-DS
,	O
Huntington	B-DS
'	I-DS
s	I-DS
disease	I-DS
,	O
inflammatory	O
response	O
).	O

For	O
details	O
of	O
the	O
datasets	O
refer	O
to	O
the	O
Supplementary	O
Table	O
1	O
in	O
Additional	O
file	O
2	O
.	O

We	O
first	O
identify	O
gene	O
pairs	O
which	O
consistently	O
demonstrate	O
higher	O
correlation	O
in	O
cancer	B-DS
versus	O
non	O
-	O
cancer	B-DS
datasets	O
based	O
on	O
a	O
robust	O
correlation	O
estimator	O
,	O
the	O
normalized	O
Percentage	O
Bend	O
correlation	O
(	O
for	O
details	O
see	O
Methods	O
).	O

In	O
following	O
sections	O
,	O
if	O
not	O
specified	O
,	O
the	O
term	O
correlation	O
will	O
by	O
default	O
refer	O
to	O
the	O
normalized	O
Percentage	O
Bend	O
correlation	O
.	O

These	O
criteria	O
result	O
in	O
6	O
,	O
035	O
gene	O
pairs	O
covering	O
1	O
,	O
967	O
genes	O
.	O

The	O
6	O
,	O
035	O
gene	O
pairs	O
,	O
each	O
representing	O
a	O
potential	O
conditional	O
functional	O
link	O
,	O
can	O
be	O
represented	O
as	O
a	O
differential	O
co	O
-	O
expression	O
network	O
.	O

In	O
this	O
network	O
,	O
each	O
gene	O
is	O
represented	O
as	O
a	O
node	O
and	O
each	O
differential	O
co	O
-	O
expression	O
relationship	O
is	O
represented	O
as	O
an	O
edge	O
.	O

It	O
has	O
been	O
reported	O
that	O
co	O
-	O
expression	O
networks	O
follow	O
a	O
scale	O
-	O
free	O
node	O
degree	O
distribution	O
[	O
7	O
].	O

We	O
observed	O
that	O
the	O
differential	O
co	O
-	O
expression	O
network	O
also	O
follows	O
such	O
a	O
topology	O
,	O
where	O
only	O
a	O
small	O
number	O
of	O
nodes	O
act	O
as	O
“	O
highly	O
connected	O
hubs	O
”	O
(	O
see	O
node	O
degree	O
distribution	O
in	O
Supplementary	O
Figure	O
1	O
in	O
Additional	O
file	O
1	O
).	O

This	O
indicates	O
that	O
most	O
gene	O
-	O
gene	O
co	O
-	O
expression	O
relationships	O
differing	O
between	O
cancer	B-DS
and	O
other	O
phenotypes	O
are	O
associated	O
with	O
only	O
a	O
few	O
“	O
hub	O
”	O
genes	O
.	O

Such	O
hub	O
genes	O
exhibit	O
a	O
high	O
degree	O
of	O
coordination	O
with	O
many	O
other	O
genes	O
in	O
neoplastic	O
states	O
,	O
and	O
are	O
therefore	O
likely	O
to	O
play	O
important	O
roles	O
in	O
carcinogenesis	O
and	O
cancer	B-DS
progression	O
.	O

In	O
fact	O
,	O
most	O
hub	O
genes	O
fall	O
into	O
two	O
main	O
functional	O
categories	O
:	O
1	O
)	O
core	O
processes	O
of	O
neoplastic	O
states	O
such	O
as	O
cell	O
division	O
and	O
chromosome	O
organization	O
;	O
or	O
2	O
)	O
dynamic	O
interactions	O
between	O
cancer	B-DS
cells	O
and	O
their	O
microenvironment	O
such	O
as	O
angiogenesis	O
,	O
immune	O
response	O
,	O
and	O
cell	O
adhesion	O
(	O
see	O
Supplementary	O
Table	O
2	O
in	O
Additional	O
file	O
2	O
).	O

For	O
those	O
hub	O
genes	O
with	O
unknown	O
functions	O
,	O
we	O
can	O
predict	O
their	O
cancer	B-DS
-	O
related	O
functions	O
based	O
on	O
their	O
neighbor	O
genes	O
.	O

For	O
example	O
,	O
the	O
16	O
out	O
of	O
the	O
33	O
interacting	O
partners	O
of	O
the	O
ADP	B-GP
-	I-GP
ribosylation	I-GP
factor	I-GP
-	I-GP
like	I-GP
6	I-GP
interacting	I-GP
protein	I-GP
(	O
ARL6IP	B-GP
)	O
are	O
involved	O
in	O
cell	O
division	O
(	O
hypergeometric	O
test	O
p	O
-	O
value	O
1	O
.	O
6	O
×	O
10	O
-	O
24	O
).	O

Thus	O
,	O
ARL6IP	B-GP
is	O
likely	O
to	O
be	O
involved	O
in	O
cell	O
proliferation	O
,	O
consistent	O
with	O
its	O
initial	O
characterization	O
as	O
an	O
interaction	O
partner	O
of	O
the	O
Ras	B-GP
superfamily	O
member	O
ARL6	B-GP
[	O
8	O
].	O

As	O
another	O
example	O
,	O
while	O
microfibrillar	B-GP
-	I-GP
associated	I-GP
protein	I-GP
2	I-GP
(	O
MFAP2	B-GP
)	O
has	O
long	O
been	O
known	O
to	O
bind	O
to	O
various	O
components	O
of	O
the	O
elastic	O
extracellular	O
matrix	O
[	O
9	O
],	O
it	O
has	O
not	O
been	O
clear	O
whether	O
it	O
serves	O
more	O
than	O
a	O
mechanical	O
function	O
.	O

We	O
found	O
that	O
6	O
out	O
of	O
its	O
24	O
neighbor	O
genes	O
are	O
involved	O
in	O
cell	O
adhesion	O
(	O
p	O
-	O
value	O
7	O
.	O
7	O
×	O
10	O
-	O
5	O
).	O

In	O
fact	O
,	O
a	O
recent	O
study	O
found	O
that	O
MFAP2	B-GP
binds	O
to	O
a	O
neighbor	O
gene	O
Notch1	B-GP
and	O
activates	O
it	O
[	O
10	O
].	O

Identification	O
of	O
pathway	O
modules	O
specific	O
to	O
cancer	B-DS
or	O
cancer	B-DS
subtypes	O

The	O
differential	O
co	O
-	O
expression	O
network	O
provides	O
a	O
summary	O
of	O
co	O
-	O
expression	O
links	O
frequently	O
active	O
across	O
all	O
types	O
of	O
cancers	B-DS
.	O

However	O
,	O
it	O
does	O
not	O
provide	O
clues	O
as	O
to	O
which	O
set	O
of	O
links	O
tend	O
to	O
be	O
simultaneously	O
active	O
and	O
inactive	O
under	O
which	O
types	O
of	O
cancer	B-DS
.	O

That	O
is	O
,	O
the	O
edges	O
of	O
a	O
differential	O
co	O
-	O
expression	O
network	O
may	O
not	O
be	O
active	O
in	O
the	O
same	O
subset	O
of	O
datasets	O
.	O

In	O
fact	O
,	O
the	O
largest	O
connected	O
component	O
of	O
the	O
differential	O
co	O
-	O
expression	O
network	O
contains	O
5944	O
edges	O
,	O
which	O
comprises	O
98	O
%	O
of	O
all	O
the	O
edges	O
in	O
the	O
network	O
.	O

Thus	O
,	O
based	O
on	O
connectivity	O
alone	O
we	O
cannot	O
break	O
the	O
network	O
into	O
functionally	O
coherent	O
and	O
cancer	B-DS
-	O
subtype	O
specific	O
modules	O
.	O

To	O
dissect	O
the	O
networks	O
,	O
we	O
integrate	O
two	O
types	O
of	O
information	O
,	O
the	O
co	O
-	O
expression	O
dynamics	O
and	O
the	O
network	O
connectivity	O
,	O
to	O
extract	O
cancer	B-DS
-	O
subtype	O
specific	O
network	O
modules	O
.	O

First	O
,	O
we	O
employ	O
the	O
second	O
-	O
order	O
clustering	O
approach	O
to	O
utilize	O
the	O
co	O
-	O
expression	O
dynamics	O
information	O
.	O

This	O
includes	O
two	O
steps	O
:	O
(	O
i	O
)	O
for	O
any	O
two	O
genes	O
connected	O
with	O
an	O
edge	O
in	O
the	O
differential	O
co	O
-	O
expression	O
network	O
,	O
we	O
calculate	O
the	O
expression	O
correlation	O
in	O
each	O
of	O
the	O
32	O
cancer	B-DS
microarray	O
datasets	O
and	O
store	O
it	O
in	O
a	O
vector	O
,	O
termed	O
the	O
first	O
-	O
order	O
expression	O
correlation	O
profile	O
of	O
the	O
genes	O
;	O
(	O
ii	O
)	O
we	O
then	O
perform	O
hierarchical	O
clustering	O
of	O
all	O
the	O
gene	O
pairs	O
based	O
on	O
the	O
Euclidean	O
distance	O
between	O
the	O
first	O
-	O
order	O
expression	O
correlation	O
profiles	O
.	O

Unlike	O
commonly	O
used	O
clustering	O
approaches	O
,	O
the	O
unit	O
of	O
the	O
second	O
-	O
order	O
clustering	O
is	O
a	O
gene	O
pair	O
instead	O
of	O
a	O
gene	O
,	O
and	O
the	O
distance	O
between	O
units	O
is	O
computed	O
based	O
on	O
the	O
first	O
-	O
order	O
expression	O
correlation	O
profiles	O
instead	O
of	O
the	O
original	O
gene	O
expression	O
profiles	O
,	O
hence	O
the	O
term	O
“	O
second	O
-	O
order	O
”	O
clustering	O
[	O
5	O
].	O

Since	O
each	O
edge	O
represents	O
a	O
frequently	O
occurring	O
co	O
-	O
expression	O
relationship	O
in	O
multiple	B-DS
cancer	I-DS
datasets	O
,	O
it	O
likely	O
represents	O
a	O
functional	O
link	O
.	O

If	O
a	O
cluster	O
of	O
gene	O
pairs	O
follows	O
the	O
same	O
co	O
-	O
expression	O
pattern	O
across	O
multiple	B-DS
cancer	I-DS
datasets	O
,	O
it	O
represents	O
a	O
module	O
of	O
functional	O
links	O
being	O
turned	O
on	O
or	O
off	O
simultaneously	O
across	O
different	O
cancer	B-DS
phenotypes	O
.	O

Given	O
a	O
second	O
-	O
order	O
cluster	O
of	O
gene	O
pairs	O
,	O
we	O
further	O
identify	O
connected	O
network	O
components	O
among	O
them	O
.	O

We	O
suggest	O
that	O
a	O
set	O
of	O
gene	O
pairs	O
is	O
more	O
likely	O
to	O
be	O
functionally	O
related	O
if	O
they	O
form	O
a	O
connected	O
component	O
(	O
see	O
Supplementary	O
document	O
in	O
Additional	O
file	O
1	O
for	O
supporting	O
analysis	O
).	O

Given	O
a	O
second	O
-	O
order	O
hierarchical	O
clustering	O
tree	O
,	O
we	O
traverse	O
the	O
tree	O
bottom	O
up	O
to	O
retrieve	O
connected	O
network	O
components	O
.	O

In	O
general	O
,	O
the	O
size	O
of	O
a	O
connected	O
component	O
(	O
S	O
,	O
the	O
number	O
of	O
edges	O
)	O
decreases	O
with	O
the	O
second	O
-	O
order	O
diameter	O
(	O
D	O
),	O
defined	O
as	O
the	O
largest	O
pairwise	O
second	O
-	O
order	O
distance	O
.	O

We	O
found	O
that	O
S	O
and	O
D	O
show	O
a	O
linear	O
scaling	O
relationship	O
in	O
a	O
logarithm	O
scale	O
(	O
see	O
Supplementary	O
Figure	O
2	O
in	O
Additional	O
file	O
1	O
).	O

We	O
are	O
especially	O
interested	O
in	O
outliers	O
–	O
network	O
components	O
small	O
in	O
D	O
but	O
large	O
in	O
S	O
,	O
which	O
represent	O
tightly	O
clustered	O
network	O
modules	O
relative	O
to	O
their	O
size	O
.	O

We	O
define	O
the	O
modularity	O
score	O
λ	O
of	O
a	O
subnetwork	O
using	O
a	O
linear	O
scaling	O
model	O
λ	O
=	O
α	O
log2	O
(	O
S	O
)	O
–	O
log2	O
(	O
D	O
)	O
–	O
β	O
,	O
where	O
α	O
and	O
β	O
are	O
estimated	O
using	O
linear	O
fitting	O
.	O

With	O
our	O
data	O
,	O
we	O
obtain	O
α	O
=	O
0	O
.	O
13	O
and	O
β	O
=	O
2	O
.	O
2	O
.	O

We	O
select	O
the	O
top	O
60	O
%	O
of	O
networks	O
(	O
S	O
>=	O
4	O
)	O
ranked	O
by	O
λ	O
scores	O
,	O
removing	O
those	O
networks	O
having	O
D	O
>=	O
0	O
.	O
34	O
,	O
and	O
merging	O
heavily	O
overlapping	O
networks	O
.	O

This	O
procedure	O
resulted	O
in	O
162	O
second	O
-	O
order	O
clusters	O
comprising	O
224	O
connected	O
network	O
modules	O
,	O
with	O
size	O
ranging	O
from	O
4	O
to	O
64	O
edges	O
.	O

Their	O
composition	O
,	O
network	O
topology	O
,	O
and	O
activation	O
status	O
across	O
various	O
cancer	B-DS
phenotypes	O
can	O
be	O
seen	O
in	O
Supplementary	O
table	O
3	O
in	O
Additional	O
file	O
2	O
.	O

175	O
(	O
78	O
%)	O
modules	O
are	O
statistically	O
significantly	O
functionally	O
homogenous	O
based	O
on	O
the	O
GeneOntology	O
Biological	O
Process	O
annotation	O
(	O
hypergeometric	O
test	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
).	O

The	O
most	O
predominant	O
functional	O
categories	O
are	O
cell	O
cycle	O
,	O
cell	O
division	O
,	O
cell	O
proliferation	O
,	O
response	O
to	O
stress	O
,	O
immune	O
response	O
and	O
cell	O
adhesion	O
(	O
see	O
Supplementary	O
Table	O
4	O
in	O
Additional	O
file	O
2	O
),	O
consistent	O
with	O
known	O
pathological	O
mechanisms	O
of	O
cancer	B-DS
.	O

General	O
cancer	B-DS
and	O
solid	B-DS
tumor	I-DS
network	O
modules	O
.	O
(	O
A	O
)	O
A	O
network	O
module	O
that	O
tend	O
to	O
activate	O
in	O
most	O
of	O
cancer	B-DS
datasets	O
,	O
consisting	O
24	O
genes	O
and	O
28	O
edges	O
.	O

Average	O
correlation	O
across	O
all	O
data	O
sets	O
is	O
0	O
.	O
42	O
.	O

Most	O
of	O
genes	O
in	O
the	O
module	O
are	O
related	O
to	O
cell	O
division	O
and	O
genetic	O
stability	O
.	O

(	O
B	O
)	O
Another	O
network	O
module	O
that	O
is	O
activated	O
in	O
most	O
of	O
cancer	B-DS
datasets	O
,	O
consisting	O
9	O
genes	O
and	O
9	O
edges	O
.	O

The	O
module	O
is	O
located	O
in	O
the	O
same	O
second	O
order	O
cluster	O
as	O
the	O
one	O
in	O
figure	O
2a	O
.	O

Its	O
average	O
correlation	O
across	O
all	O
datasets	O
is	O
0	O
.	O
39	O
.	O

Most	O
of	O
genes	O
in	O
the	O
module	O
are	O
related	O
to	O
nucleobase	O
,	O
nucleoside	O
,	O
nucleotide	O
and	O
nucleic	O
acid	O
metabolism	O
.	O

(	O
C	O
)	O
Left	O
:	O
a	O
network	O
that	O
tends	O
to	O
be	O
activated	O
only	O
in	O
solid	B-DS
tumor	I-DS
datasets	O
.	O

Right	O
,	O
the	O
co	O
-	O
expression	O
heatmap	O
of	O
the	O
edges	O
across	O
datasets	O
.	O

Six	O
datasets	O
are	O
not	O
shown	O
in	O
the	O
heatmap	O
due	O
to	O
lack	O
of	O
valid	O
co	O
-	O
expression	O
estimations	O
.	O

Average	O
correlation	O
in	O
solid	B-DS
tumor	I-DS
datasets	O
and	O
other	O
datasets	O
are	O
0	O
.	O
61	O
and	O
0	O
.	O
17	O
,	O
respectively	O
.	O

One	O
main	O
feature	O
of	O
our	O
approach	O
is	O
that	O
it	O
can	O
simultaneously	O
discover	O
network	O
modules	O
and	O
the	O
types	O
of	O
cancer	B-DS
in	O
which	O
the	O
modules	O
are	O
activated	O
.	O

Figure	O
2a	O
shows	O
a	O
module	O
that	O
is	O
activated	O
in	O
most	O
of	O
the	O
cancer	B-DS
datasets	O
.	O

The	O
genes	O
of	O
the	O
module	O
are	O
mostly	O
involved	O
in	O
cell	O
division	O
and	O
genetic	O
stability	O
,	O
representing	O
a	O
cell	O
proliferation	O
signature	O
,	O
a	O
key	O
feature	O
of	O
cancer	B-DS
.	O

Figure	O
2c	O
shows	O
a	O
network	O
module	O
which	O
tends	O
to	O
be	O
activated	O
in	O
only	O
solid	B-DS
tumors	I-DS
.	O

The	O
genes	O
of	O
the	O
module	O
are	O
mostly	O
involved	O
in	O
cell	O
adhesion	O
and	O
organogenesis	O
,	O
which	O
is	O
specific	O
to	O
solid	B-DS
tumor	I-DS
versus	O
blood	B-DS
cancers	I-DS
or	O
neoplastic	O
cell	O
lines	O
.	O

In	O
the	O
next	O
section	O
,	O
we	O
will	O
detail	O
two	O
network	O
modules	O
which	O
are	O
activated	O
predominately	O
in	O
breast	B-DS
cancer	I-DS
data	O
sets	O
.	O

Network	O
modules	O
in	O
the	O
breast	B-DS
cancer	I-DS
cluster	O

Our	O
analysis	O
resulted	O
in	O
a	O
second	O
-	O
order	O
cluster	O
containing	O
two	O
connected	O
network	O
modules	O
that	O
tend	O
to	O
be	O
more	O
active	O
in	O
all	O
seven	O
breast	B-DS
tumor	I-DS
datasets	O
relative	O
to	O
the	O
rest	O
of	O
the	O
datasets	O
.	O

The	O
average	O
correlation	O
of	O
these	O
modules	O
in	O
breast	B-DS
tumor	I-DS
and	O
other	O
cancer	B-DS
datasets	O
are	O
0	O
.	O
49	O
and	O
0	O
.	O
23	O
respectively	O
(	O
the	O
t	O
-	O
test	O
of	O
co	O
-	O
expressions	O
between	O
breast	B-DS
tumor	I-DS
and	O
the	O
rest	O
of	O
cancer	B-DS
datasets	O
gives	O
a	O
p	O
-	O
value	O
of	O
1	O
.	O
56	O
×	O
10	O
-	O
95	O
).	O

A	O
tumor	B-DS
suppressor	O
network	O
related	O
to	O
PDGF	B-GP
superfamily	O
signaling	O

The	O
module	O
in	O
Figure	O
3a	O
contains	O
52	O
genes	O
.	O

Most	O
of	O
them	O
are	O
extracellular	O
or	O
membrane	B-GP
proteins	I-GP
,	O
and	O
23	O
genes	O
have	O
previously	O
been	O
found	O
to	O
be	O
involved	O
in	O
breast	B-DS
cancer	I-DS
.	O

A	O
number	O
of	O
such	O
examples	O
are	O
listed	O
in	O
Supplementary	O
document	O
in	O
Additional	O
file	O
1	O
.	O

Among	O
the	O
52	O
genes	O
,	O
16	O
are	O
involved	O
in	O
cell	O
adhesion	O
(	O
p	O
-	O
value	O
7	O
.	O
4	O
×	O
10	O
-	O
11	O
),	O
and	O
14	O
are	O
involved	O
cell	O
-	O
cell	O
signalling	O
(	O
p	O
-	O
value	O
7	O
.	O
9	O
×	O
10	O
-	O
6	O
),	O
suggesting	O
a	O
role	O
in	O
tumor	B-DS
invasiveness	O
of	O
the	O
module	O
[	O
11	O
].	O

Coordinated	O
breast	B-DS
tumor	I-DS
network	O
modules	O
(	O
A	O
)	O
A	O
breast	B-DS
tumor	I-DS
network	O
module	O
that	O
involved	O
in	O
PDGF	B-GP
signalling	O
.	O

Genes	O
in	O
round	O
shape	O
have	O
promoter	O
regions	O
that	O
are	O
predicted	O
to	O
be	O
bound	O
by	O
transcription	B-GP
factor	I-GP
ZNF148	B-GP
.	O

(	O
B	O
)	O
A	O
breast	B-DS
tumor	I-DS
network	O
module	O
related	O
to	O
inflammatory	O
response	O
,	O
located	O
in	O
the	O
same	O
second	O
-	O
order	O
cluster	O
as	O
the	O
one	O
in	O
Figure	O
3a	O
.	O

Genes	O
in	O
round	O
shape	O
have	O
promoter	O
regions	O
that	O
are	O
predicted	O
to	O
be	O
bound	O
by	O
transcription	B-GP
factor	I-GP
POU2F1	B-GP
.	O

Most	O
interestingly	O
,	O
we	O
found	O
one	O
main	O
function	O
of	O
this	O
network	O
module	O
appears	O
to	O
be	O
tumor	B-DS
suppression	O
via	O
the	O
inhibition	O
of	O
PDGF	B-GP
superfamily	O
signaling	O
.	O

A	O
hub	O
gene	O
with	O
high	O
degree	O
of	O
this	O
module	O
is	O
the	O
gene	O
PDGF	B-GP
receptor	I-GP
-	I-GP
like	I-GP
(	O
PDGFRL	B-GP
)	O
(	O
degree	O
11	O
).	O

While	O
its	O
precise	O
biological	O
function	O
is	O
not	O
known	O
,	O
PDGFRL	B-GP
encodes	O
a	O
375aa	O
product	O
with	O
significant	O
sequence	O
similarity	O
to	O
the	O
extracellular	O
domain	O
of	O
PDGFR	B-GP
.	O

Indeed	O
,	O
mutations	O
in	O
PDGFRL	B-GP
have	O
been	O
found	O
in	O
individual	O
cancer	B-DS
samples	O
[	O
12	O
-	O
15	O
].	O

PDGFRL	B-GP
is	O
located	O
in	O
chromosome	O
8p22	O
-	O
8p21	O
.	O
3	O
,	O
where	O
multiple	O
studies	O
have	O
suggested	O
the	O
existence	O
of	O
a	O
putative	O
breast	B-DS
cancer	I-DS
tumor	B-DS
suppressor	O
gene	O
[	O
16	O
],	O
[	O
17	O
],	O
[	O
18	O
].	O

Recently	O
,	O
an	O
in	O
-	O
depth	O
study	O
of	O
the	O
region	O
using	O
microcell	O
-	O
mediated	O
chromosome	O
transfer	O
found	O
that	O
indeed	O
PDGFRL	B-GP
expression	O
is	O
decreased	O
in	O
the	O
majority	O
of	O
breast	B-DS
cancer	I-DS
cells	O
[	O
19	O
].	O

Many	O
genes	O
in	O
this	O
network	O
module	O
have	O
been	O
found	O
to	O
be	O
involved	O
in	O
PDGF	B-GP
superfamily	O
signaling	O
.	O

For	O
example	O
,	O
Cysteine	B-GP
-	I-GP
rich	I-GP
protein	I-GP
(	O
SPARC	B-GP
)	O
binds	O
to	O
PDGF	B-GP
-	O
AB	O
and	O
PDGF	B-GP
-	O
BB	O
dimers	O
,	O
inhibiting	O
the	O
binding	O
of	O
these	O
growth	O
factors	O
to	O
their	O
cell	B-GP
surface	I-GP
receptors	I-GP
[	O
20	O
]	O
and	O
inhibiting	O
PDGF	B-GP
-	O
induced	O
vascular	O
smooth	O
muscle	O
proliferation	O
[	O
21	O
].	O

Also	O
,	O
connective	B-GP
tissue	I-GP
growth	I-GP
factor	I-GP
(	O
CTGF	B-GP
)	O
has	O
structural	O
similarities	O
with	O
PDGF	B-GP
[	O
22	O
].	O

Recently	O
,	O
two	O
new	O
PDGF	B-GP
ligands	O
were	O
discovered	O
that	O
have	O
a	O
N	O
-	O
terminal	O
complement	O
subcomponent	O
C1R	B-GP
/	O
C1S	B-GP
,	O
UEGf	B-GP
,	O
BMP1	B-GP
(	O
CUB	O
)	O
domain	O
[	O
23	O
].	O

Interestingly	O
both	O
C1R	B-GP
and	O
C1S	B-GP
are	O
members	O
of	O
this	O
network	O
module	O
.	O

Also	O
,	O
LRP1	B-GP
is	O
a	O
physiological	O
modulator	O
of	O
the	O
PDGF	B-GP
signaling	O
pathway	O
[	O
24	O
].	O

In	O
total	O
,	O
we	O
found	O
direct	O
Pubmed	O
literature	O
support	O
for	O
19	O
out	O
of	O
the	O
52	O
member	O
genes	O
to	O
be	O
involved	O
in	O
(	O
or	O
related	O
to	O
)	O
the	O
PDGF	B-GP
-	O
superfamily	O
signalling	O
.	O

Furthermore	O
,	O
it	O
is	O
known	O
that	O
zinc	B-GP
finger	I-GP
protein	I-GP
(	O
ZNF148	B-GP
)	O
binds	O
to	O
the	O
PDGFR	B-GP
[	O
25	O
]	O
gene	O
promoter	O
.	O

We	O
screened	O
the	O
promoter	O
regions	O
of	O
the	O
52	O
member	O
genes	O
,	O
and	O
found	O
that	O
the	O
binding	O
sites	O
of	O
ZNF148	B-GP
are	O
significantly	O
enriched	O
(	O
hypergeometric	O
p	O
-	O
value	O
0	O
.	O
016	O
).	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
PDGFR	B-GP
positively	O
regulates	O
collagen	O
production	O
(	O
for	O
example	O
[	O
26	O
],	O
[	O
27	O
]).	O

Our	O
module	O
showed	O
the	O
breast	B-DS
tumor	I-DS
specific	O
co	O
-	O
expression	O
between	O
PDGFRL	B-GP
and	O
collagens	B-GP
COL3A1	B-GP
,	O
COL5A2	B-GP
and	O
COL6A3	B-GP
.	O

Many	O
of	O
the	O
above	O
evidences	O
support	O
the	O
hypothesis	O
that	O
PDGFRL	B-GP
has	O
an	O
agonistic	O
function	O
to	O
PDGFR	B-GP
signaling	O
.	O

Although	O
abundant	O
evidence	O
suggests	O
the	O
individual	O
involvement	O
of	O
many	O
of	O
these	O
genes	O
in	O
tumor	B-DS
suppression	O
,	O
their	O
coordinated	O
function	O
has	O
never	O
been	O
elucidated	O
.	O

Here	O
by	O
adopting	O
a	O
network	O
perspective	O
,	O
we	O
have	O
identified	O
their	O
interrelationships	O
and	O
a	O
gene	O
(	O
PDGFRL	B-GP
)	O
that	O
may	O
play	O
a	O
central	O
role	O
in	O
this	O
tumor	B-DS
suppressor	O
network	O
.	O

A	O
network	O
module	O
related	O
to	O
inflammatory	O
response	O

Another	O
identified	O
breast	B-DS
cancer	I-DS
-	O
specific	O
network	O
module	O
(	O
Figure	O
3b	O
)	O
may	O
be	O
involved	O
in	O
the	O
coordination	O
of	O
the	O
inflammatory	O
response	O
to	O
cancer	B-DS
pathology	O
.	O

This	O
network	O
consists	O
of	O
5	O
genes	O
:	O
tumor	B-GP
necrosis	I-GP
factor	I-GP
receptor	I-GP
superfamily	I-GP
member	I-GP
1B	I-GP
(	O
TNFRSF1B	B-GP
);	O
vascular	B-GP
cell	I-GP
adhesion	I-GP
molecule	I-GP
1	I-GP
(	O
VCAM1	B-GP
);	O
leukocyte	B-GP
-	I-GP
associated	I-GP
immunoglobulin	I-GP
-	I-GP
like	I-GP
receptor	I-GP
1	I-GP
(	O
LAIR1	B-GP
);	O
and	O
Cathepsin	B-GP
L1	I-GP
(	O
CSTL	B-GP
).	O

They	O
are	O
arranged	O
around	O
the	O
macrophage	B-GP
-	I-GP
associated	I-GP
antigen	I-GP
(	O
CD163	B-GP
).	O

Several	O
lines	O
of	O
evidence	O
have	O
implicated	O
these	O
genes	O
individually	O
in	O
breast	B-DS
cancer	I-DS
,	O
for	O
example	O
:	O
increased	O
plasma	O
levels	O
of	O
VCAM1	B-GP
is	O
associated	O
with	O
advanced	B-DS
breast	I-DS
cancer	I-DS
[	O
28	O
];	O
genetic	O
variation	O
in	O
TNFRSF1B	B-GP
may	O
predict	O
the	O
late	O
onset	O
of	O
breast	B-DS
carcinoma	I-DS
,	O
and	O
relapse	O
and	O
death	O
for	O
patients	O
with	O
breast	B-DS
carcinoma	I-DS
[	O
29	O
];	O
finally	O
,	O
the	O
breast	B-DS
cancer	I-DS
cell	O
line	O
exhibiting	O
the	O
highest	O
in	O
vitro	O
invasiveness	O
also	O
expressed	O
the	O
highest	O
amount	O
of	O
CTSL1	B-GP
splice	O
variant	O
L	O
-	O
A3	O
[	O
30	O
].	O

Most	O
of	O
the	O
genes	O
of	O
this	O
module	O
are	O
related	O
to	O
tumor	B-GP
necrosis	I-GP
factor	I-GP
(	O
TNF	B-GP
),	O
an	O
inflammatory	B-GP
cytokine	I-GP
.	O

It	O
has	O
been	O
reported	O
that	O
activation	O
of	O
rat	B-OG
CD163	B-GP
on	O
peritoneal	O
macrophages	O
induces	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
mediators	O
including	O
TNF	B-GP
[	O
31	O
];	O
TNF	B-GP
directly	O
interacts	O
with	O
TNFRSF1B	B-GP
[	O
32	O
]	O
and	O
is	O
a	O
mediator	O
of	O
TNF	B-GP
function	O
in	O
the	O
mouse	B-OG
ovary	O
[	O
33	O
].	O

Finally	O
,	O
transcription	O
of	O
VCAM1	B-GP
in	O
endothelial	O
cells	O
can	O
be	O
induced	O
by	O
TNF	B-GP
[	O
34	O
].	O

A	O
transcription	B-GP
factor	I-GP
,	O
octamer	B-GP
-	I-GP
binding	I-GP
transcription	I-GP
factor	I-GP
-	I-GP
1	I-GP
(	O
POU2F1	B-GP
,	O
also	O
known	O
as	O
Oct	B-GP
-	I-GP
1	I-GP
)	O
has	O
been	O
predicted	O
to	O
bind	O
promoter	O
region	O
of	O
VCAM1	B-GP
,	O
LAIR1	B-GP
and	O
CTSL	B-GP
(	O
hypergeometric	O
p	O
-	O
value	O
0	O
.	O
012	O
).	O

The	O
binding	O
of	O
POU2F1	B-GP
to	O
VCAM1	B-GP
promoter	O
is	O
indeed	O
supported	O
by	O
the	O
literature	O
[	O
35	O
-	O
37	O
].	O

Also	O
,	O
POU2F1	B-GP
has	O
been	O
found	O
to	O
bind	O
SP3	B-GP
[	O
38	O
],	O
which	O
is	O
reported	O
to	O
activate	O
the	O
transcription	O
of	O
CSTL	B-GP
[	O
39	O
].	O

The	O
tight	O
and	O
coordinated	O
expression	O
of	O
the	O
genes	O
in	O
this	O
network	O
module	O
reveals	O
an	O
induced	O
inflammatory	O
response	O
that	O
may	O
be	O
important	O
in	O
breast	B-DS
tumor	I-DS
progression	O
[	O
40	O
].	O

Identification	O
of	O
pathway	O
coordination	O
beyond	O
co	O
-	O
expression	O

A	O
major	O
advantage	O
of	O
second	O
-	O
order	O
clustering	O
is	O
that	O
it	O
can	O
identify	O
functionally	O
related	O
genes	O
beyond	O
co	O
-	O
expression	O
,	O
as	O
illustrated	O
in	O
Figure	O
1b	O
.	O

We	O
elaborate	O
on	O
this	O
point	O
in	O
this	O
section	O
.	O

To	O
allow	O
readers	O
to	O
easily	O
assess	O
the	O
magnitude	O
of	O
the	O
correlation	O
,	O
only	O
in	O
this	O
section	O
we	O
use	O
the	O
Pearson	O
correlation	O
to	O
measure	O
the	O
co	O
-	O
expression	O
level	O
.	O

Based	O
on	O
the	O
definition	O
of	O
second	O
-	O
order	O
clustering	O
,	O
connected	O
network	O
components	O
within	O
the	O
same	O
second	O
-	O
order	O
cluster	O
show	O
coordinated	O
activities	O
,	O
which	O
implies	O
their	O
functional	O
relevance	O
.	O

In	O
the	O
example	O
of	O
the	O
two	O
modules	O
in	O
the	O
general	O
cancer	B-DS
cluster	O
in	O
Figure	O
2a	O
and	O
2b	O
,	O
each	O
module	O
may	O
play	O
different	O
roles	O
in	O
the	O
regulation	O
of	O
specific	O
biological	O
processes	O
--	O
cell	O
division	O
and	O
nucleic	O
acid	O
metabolism	O
,	O
respectively	O
;	O
the	O
latter	O
is	O
clearly	O
required	O
for	O
cell	O
division	O
.	O

Given	O
the	O
fact	O
that	O
these	O
processes	O
belong	O
to	O
the	O
same	O
second	O
-	O
order	O
cluster	O
,	O
they	O
may	O
represent	O
facets	O
of	O
the	O
same	O
underlying	O
neoplastic	O
process	O
.	O

However	O
,	O
member	O
genes	O
of	O
the	O
two	O
modules	O
exhibit	O
distinct	O
expression	O
patterns	O
:	O
The	O
average	O
Pearson	O
correlation	O
between	O
genes	O
of	O
the	O
two	O
modules	O
is	O
only	O
0	O
.	O
13	O
.	O

As	O
another	O
example	O
,	O
the	O
two	O
breast	B-DS
cancer	I-DS
modules	O
described	O
in	O
last	O
section	O
are	O
also	O
related	O
.	O

Indeed	O
,	O
the	O
collaboration	O
of	O
PDGF	B-GP
signalling	O
and	O
TNF	B-GP
have	O
long	O
been	O
known	O
to	O
be	O
required	O
for	O
tissue	O
repairing	O
[	O
41	O
],	O
and	O
their	O
abnormal	O
expression	O
play	O
important	O
but	O
partially	O
defined	O
roles	O
in	O
breast	B-DS
tumor	I-DS
development	O
and	O
progression	O
[	O
42	O
].	O

On	O
the	O
other	O
hand	O
,	O
member	O
genes	O
of	O
the	O
two	O
modules	O
exhibit	O
relatively	O
distinct	O
expression	O
patterns	O
.	O

For	O
example	O
,	O
two	O
hub	O
genes	O
of	O
modules	O
,	O
PDGFRL	B-GP
and	O
CD163	B-GP
,	O
also	O
show	O
very	O
weak	O
expression	O
similarities	O
across	O
all	O
seven	O
breast	B-DS
cancer	I-DS
datasets	O
:	O
the	O
average	O
Pearson	O
correlation	O
between	O
these	O
two	O
genes	O
is	O
only	O
0	O
.	O
24	O
.	O

Besides	O
the	O
above	O
examples	O
,	O
we	O
found	O
coordinated	O
modules	O
within	O
the	O
majority	O
of	O
identified	O
second	O
-	O
order	O
clusters	O
.	O

Overall	O
,	O
from	O
the	O
total	O
162	O
second	O
-	O
order	O
clusters	O
,	O
25	O
%	O
give	O
rise	O
to	O
more	O
than	O
one	O
connected	O
network	O
module	O
.	O

To	O
estimate	O
the	O
amount	O
of	O
cross	O
module	O
co	O
-	O
expression	O
within	O
second	O
-	O
order	O
clusters	O
,	O
for	O
each	O
second	O
order	O
cluster	O
,	O
we	O
first	O
determined	O
the	O
active	O
cancer	B-DS
datasets	O
,	O
in	O
which	O
the	O
average	O
Pearson	O
correlation	O
of	O
gene	O
pairs	O
in	O
the	O
cluster	O
is	O
greater	O
than	O
0	O
.	O
5	O
.	O

For	O
72	O
%	O
of	O
those	O
module	O
pairs	O
within	O
the	O
same	O
second	O
-	O
order	O
cluster	O
,	O
the	O
average	O
gene	O
pairwise	O
Pearson	O
correlation	O
between	O
modules	O
in	O
the	O
active	O
datasets	O
is	O
less	O
than	O
0	O
.	O
5	O
(	O
normalized	O
Percentage	O
Bend	O
correlation	O
approximately	O
<	O
0	O
.	O
35	O
),	O
and	O
for	O
30	O
%	O
module	O
pairs	O
the	O
cross	O
-	O
module	O
average	O
gene	O
pairwise	O
Pearson	O
correlation	O
is	O
less	O
than	O
0	O
.	O
3	O
(	O
normalized	O
Percentage	O
Bend	O
correlation	O
approximately	O
<	O
0	O
.	O
19	O
).	O

Furthermore	O
,	O
even	O
genes	O
in	O
the	O
same	O
network	O
module	O
are	O
not	O
necessarily	O
highly	O
co	O
-	O
expressed	O
when	O
the	O
module	O
is	O
active	O
,	O
despite	O
their	O
high	O
degree	O
of	O
functional	O
homogeneity	O
,	O
as	O
discussed	O
previously	O
.	O

We	O
found	O
that	O
in	O
32	O
of	O
224	O
(	O
14	O
%)	O
modules	O
,	O
the	O
average	O
pairwise	O
Pearson	O
correlation	O
of	O
any	O
two	O
genes	O
in	O
the	O
module	O
is	O
<	O
0	O
.	O
5	O
in	O
the	O
corresponding	O
active	O
datasets	O
.	O

Such	O
modules	O
could	O
therefore	O
easily	O
be	O
overlooked	O
by	O
traditional	O
clustering	O
methods	O
.	O

Discussion	O

The	O
rapid	O
accumulation	O
of	O
microarray	O
data	O
provides	O
unprecedented	O
opportunities	O
to	O
study	O
the	O
molecular	O
mechanisms	O
underlying	O
disease	O
pathogenesis	O
and	O
progression	O
.	O

Although	O
many	O
studies	O
utilized	O
multiple	O
microarray	O
datasets	O
to	O
derive	O
consistent	O
lists	O
of	O
genes	O
specific	O
for	O
(	O
subtypes	O
of	O
)	O
cancer	B-DS
[	O
43	O
-	O
45	O
],	O
little	O
attention	O
has	O
been	O
paid	O
to	O
derive	O
genetic	O
networks	O
characterizing	O
different	O
types	O
of	O
cancer	B-DS
.	O

Segal	O
et	O
al	O
.	O
[	O
46	O
]	O
used	O
predefined	O
biologically	O
meaningful	O
gene	O
sets	O
including	O
known	O
biological	O
pathways	O
,	O
and	O
have	O
successfully	O
identified	O
activated	O
or	O
repressed	O
biological	O
modules	O
in	O
a	O
wide	O
variety	O
of	O
neoplastic	O
conditions	O
.	O

The	O
approach	O
,	O
however	O
,	O
relies	O
on	O
the	O
knowledge	O
of	O
pre	O
-	O
defined	O
biological	O
modules	O
and	O
has	O
limited	O
use	O
in	O
the	O
discovery	O
of	O
novel	O
association	O
between	O
genes	O
.	O

A	O
recent	O
study	O
by	O
Choi	O
et	O
al	O
.	O
[	O
47	O
]	O
compared	O
the	O
two	O
co	O
-	O
expression	O
networks	O
summarized	O
from	O
10	O
tumor	B-DS
and	O
normal	O
datasets	O
,	O
respectively	O
,	O
and	O
have	O
identified	O
functional	O
differences	O
between	O
normal	O
growth	O
and	O
cancer	B-DS
in	O
terms	O
of	O
gene	O
coexpression	O
changes	O
in	O
broad	O
areas	O
of	O
physiology	O
.	O

However	O
,	O
due	O
to	O
the	O
multifaceted	O
nature	O
of	O
cancer	B-DS
,	O
interactions	O
in	O
such	O
a	O
derived	O
summary	O
network	O
may	O
not	O
be	O
simultaneously	O
active	O
in	O
individual	O
datasets	O
,	O
i	O
.	O
e	O
.	O
specific	O
cancer	B-DS
conditions	O
.	O

In	O
this	O
study	O
,	O
we	O
propose	O
an	O
unsupervised	O
method	O
that	O
integrates	O
both	O
co	O
-	O
expression	O
dynamics	O
and	O
network	O
topology	O
information	O
to	O
characterize	O
cancer	B-DS
(	O
subtype	O
)	O
specific	O
network	O
modules	O
.	O

The	O
identified	O
modules	O
,	O
such	O
as	O
modules	O
activated	O
across	O
all	O
cancer	B-DS
subtypes	O
or	O
only	O
in	O
solid	B-DS
tumors	I-DS
,	O
are	O
novel	O
,	O
but	O
consistent	O
with	O
known	O
molecular	O
mechanisms	O
.	O

Importantly	O
,	O
we	O
have	O
discovered	O
a	O
potential	O
tumor	B-DS
suppressor	O
network	O
particularly	O
active	O
in	O
breast	B-DS
tumors	I-DS
,	O
and	O
provide	O
compelling	O
evidence	O
that	O
the	O
hub	O
gene	O
PDGFRL	B-GP
is	O
a	O
true	O
tumor	B-DS
suppressor	O
gene	O
.	O

Compared	O
to	O
commonly	O
used	O
differential	O
or	O
co	O
-	O
expression	O
analysis	O
,	O
our	O
approach	O
has	O
the	O
following	O
advantages	O
:	O
(	O
1	O
)	O
our	O
unsupervised	O
approach	O
simultaneously	O
discovers	O
network	O
modules	O
and	O
the	O
conditions	O
(	O
e	O
.	O
g	O
.	O
cancer	B-DS
subtypes	O
)	O
in	O
which	O
they	O
are	O
activated	O
,	O
thus	O
providing	O
new	O
insights	O
into	O
the	O
complex	O
cellular	O
mechanisms	O
that	O
characterize	O
cancer	B-DS
and	O
cancer	B-DS
subtypes	O
.	O

(	O
2	O
)	O
Compared	O
to	O
existing	O
approaches	O
[	O
47	O
-	O
51	O
]	O
which	O
can	O
only	O
identify	O
densely	O
connected	O
network	O
modules	O
based	O
solely	O
on	O
network	O
topology	O
information	O
,	O
our	O
approach	O
incorporating	O
co	O
-	O
expression	O
dynamics	O
information	O
(	O
second	O
-	O
order	O
similarity	O
)	O
can	O
extract	O
more	O
diverse	O
types	O
of	O
modules	O
regardless	O
of	O
network	O
density	O
.	O

It	O
is	O
known	O
that	O
many	O
biological	O
pathways	O
do	O
not	O
necessarily	O
form	O
densely	O
connected	O
modules	O
.	O

(	O
3	O
)	O
Our	O
approach	O
can	O
reveal	O
coordination	O
of	O
pathways	O
beyond	O
co	O
-	O
expression	O
.	O

(	O
4	O
)	O
Our	O
method	O
can	O
be	O
applied	O
to	O
any	O
types	O
of	O
molecular	O
networks	O
beyond	O
co	O
-	O
expression	O
network	O
,	O
when	O
data	O
of	O
multiple	O
networks	O
under	O
different	O
conditions	O
are	O
available	O
.	O

In	O
the	O
current	O
framework	O
,	O
the	O
selection	O
of	O
biologically	O
meaningful	O
modules	O
still	O
need	O
certain	O
amount	O
of	O
manual	O
intervention	O
from	O
biology	O
expert	O
.	O

We	O
are	O
looking	O
for	O
more	O
systematic	O
ways	O
for	O
module	O
selection	O
,	O
especially	O
by	O
putting	O
the	O
framework	O
into	O
the	O
context	O
of	O
network	O
statistics	O
to	O
improve	O
the	O
robustness	O
.	O

For	O
example	O
,	O
although	O
the	O
scaling	O
model	O
we	O
constructed	O
is	O
based	O
on	O
direct	O
observation	O
of	O
the	O
distribution	O
of	O
network	O
properties	O
S	O
and	O
D	O
,	O
their	O
log	O
-	O
linear	O
relationship	O
suggests	O
that	O
it	O
should	O
be	O
straightforward	O
to	O
make	O
use	O
of	O
the	O
exponential	O
random	O
graph	O
models	O
that	O
have	O
been	O
used	O
in	O
recent	O
years	O
to	O
study	O
statistical	O
aspects	O
of	O
networks	O
[	O
52	O
].	O

In	O
essence	O
,	O
such	O
models	O
linearly	O
combine	O
network	O
properties	O
and	O
assign	O
the	O
probability	O
of	O
observed	O
networks	O
as	O
the	O
exponential	O
of	O
such	O
linear	O
combinations	O
.	O

Integrating	O
this	O
work	O
with	O
the	O
exponential	O
family	O
probabilistic	O
models	O
may	O
provide	O
both	O
better	O
estimation	O
of	O
the	O
coefficients	O
in	O
the	O
linear	O
scaling	O
model	O
and	O
more	O
accurate	O
selection	O
of	O
network	O
modules	O
via	O
hypothesis	O
testing	O
.	O

We	O
intend	O
to	O
explore	O
this	O
direction	O
in	O
future	O
work	O
.	O

The	O
choice	O
of	O
datasets	O
depends	O
on	O
the	O
research	O
question	O
.	O

Ideally	O
there	O
should	O
be	O
a	O
balanced	O
and	O
sufficient	O
sampling	O
of	O
different	O
phenotypes	O
(	O
in	O
particular	O
different	O
tissues	O
for	O
this	O
cancer	B-DS
study	O
).	O

Particularly	O
,	O
a	O
paired	O
Wilcoxon	O
test	O
between	O
cancer	B-DS
and	O
normal	O
samples	O
of	O
the	O
same	O
tissue	O
would	O
significantly	O
eliminate	O
the	O
amount	O
of	O
tissue	O
-	O
specific	O
co	O
-	O
expressions	O
.	O

However	O
,	O
due	O
to	O
the	O
limited	O
amount	O
and	O
the	O
heterogeneity	O
of	O
existing	O
data	O
it	O
is	O
currently	O
impractical	O
to	O
achieve	O
this	O
goal	O
.	O

Using	O
a	O
weighted	O
sampling	O
scheme	O
could	O
potentially	O
bypass	O
the	O
imbalance	O
effects	O
.	O

We	O
aim	O
to	O
investigate	O
this	O
strategy	O
,	O
and	O
use	O
statistical	O
models	O
of	O
the	O
correlation	O
values	O
to	O
determine	O
the	O
weighting	O
factors	O
.	O

Methods	O

Datasets	O

We	O
curated	O
32	O
cancer	B-DS
and	O
23	O
non	O
-	O
cancer	B-DS
human	B-OG
gene	O
expression	O
datasets	O
mainly	O
from	O
the	O
Stanford	O
Microarray	O
Database	O
(	O
SMD	O
)	O
and	O
Gene	O
Expression	O
Omnibus	O
(	O
GEO	O
)	O
databases	O
,	O
each	O
containing	O
more	O
than	O
15	O
microarrays	O
,	O
on	O
either	O
Affymetrix	O
or	O
cDNA	O
platforms	O
.	O

In	O
each	O
dataset	O
,	O
if	O
there	O
are	O
multiple	O
probes	O
that	O
correspond	O
to	O
the	O
same	O
gene	O
,	O
we	O
choose	O
the	O
one	O
that	O
contains	O
the	O
least	O
amount	O
of	O
missing	O
values	O
.	O

For	O
datasets	O
containing	O
absolute	O
expression	O
measurements	O
,	O
we	O
convert	O
all	O
values	O
<=	O
10	O
to	O
10	O
,	O
then	O
perform	O
a	O
base	O
2	O
log	O
transform	O
.	O

Estimation	O
of	O
Pairwise	O
gene	O
co	O
-	O
expression	O

We	O
used	O
Percentage	O
Bend	O
Correlation	O
[	O
53	O
]	O
(	O
with	O
β	O
=	O
0	O
.	O
05	O
)	O
to	O
obtain	O
a	O
robust	O
correlation	O
estimate	O
.	O

Percentage	O
Bend	O
Correlation	O
first	O
detects	O
outliers	O
in	O
expression	O
values	O
of	O
each	O
gene	O
then	O
reduces	O
the	O
effects	O
of	O
those	O
outliers	O
in	O
the	O
correlation	O
calculation	O
.	O

Only	O
gene	O
pairs	O
with	O
a	O
large	O
number	O
of	O
valid	O
samples	O
m	O
>=	O
15	O
are	O
used	O
to	O
calculate	O
correlation	O
.	O

To	O
make	O
the	O
correlation	O
estimates	O
comparable	O
across	O
different	O
datasets	O
of	O
variable	O
sample	O
sizes	O
and	O
among	O
different	O
gene	O
pairs	O
of	O
different	O
amount	O
of	O
missing	O
expression	O
measures	O
within	O
the	O
same	O
dataset	O
,	O
we	O
performed	O
Fisher	O
'	O
s	O
z	O
-	O
transform	O
[	O
54	O
]	O
to	O
reduce	O
sample	O
size	O
effect	O
.	O

Given	O
a	O
correlation	O
estimate	O
r	O
and	O
sample	O
size	O
n	O
,	O
the	O
Fisher	O
'	O
s	O
Z	O
scores	O
(	O
divided	O
by	O
its	O
theoretical	O
standard	O
deviation	O
)	O
is	O
calculated	O
as	O
z	O
=	O
n	O
−	O
32log	O
⁡(	O
1	O
+	O
r1	O
−	O
r	O
),	O
which	O
theoretically	O
has	O
an	O
asymptotically	O
standard	O
normal	O
distribution	O
.	O

Note	O
that	O
sample	O
size	O
n	O
may	O
be	O
different	O
from	O
gene	O
pair	O
to	O
gene	O
pair	O
due	O
to	O
missing	O
values	O
,	O
and	O
from	O
dataset	O
to	O
dataset	O
.	O

In	O
reality	O
,	O
we	O
observed	O
that	O
the	O
distributions	O
of	O
the	O
z	O
-	O
score	O
are	O
still	O
different	O
from	O
dataset	O
to	O
dataset	O
:	O
we	O
therefore	O
normalized	O
z	O
-	O
scores	O
to	O
enforce	O
the	O
standard	O
normal	O
distribution	O
.	O

After	O
that	O
,	O
standardized	O
correlations	O
r	O
'	O
are	O
obtained	O
by	O
inverting	O
the	O
z	O
-	O
score	O
with	O
a	O
fixed	O
n	O
of	O
30	O
.	O

Select	O
differentially	O
co	O
-	O
expressed	O
gene	O
pairs	O

We	O
define	O
a	O
gene	O
pair	O
to	O
be	O
differentially	O
co	O
-	O
expressed	O
between	O
cancer	B-DS
and	O
non	O
-	O
cancer	B-DS
if	O
it	O
satisfies	O
the	O
following	O
two	O
criteria	O
:	O
(	O
1	O
)	O
their	O
expression	O
correlation	O
in	O
cancer	B-DS
datasets	O
is	O
sufficiently	O
strong	O
(	O
can	O
be	O
either	O
positively	O
or	O
negatively	O
high	O
).	O

This	O
is	O
done	O
by	O
setting	O
threshold	O
for	O
average	O
summed	O
square	O
of	O
correlations	O
in	O
cancer	B-DS
datasets	O
.	O
i	O
.	O
e	O
,	O
1c	O
∑	O
k	O
(	O
ri	O
(	O
k	O
))	O
2	O
≥	O
0	O
.	O
35	O
for	O
the	O
gene	O
pair	O
i	O
,	O
where	O
there	O
are	O
c	O
valid	O
correlation	O
estimations	O
(	O
c	O
=	O
32	O
if	O
there	O
are	O
no	O
missing	O
values	O
)	O
and	O
k	O
is	O
dataset	O
index	O
corresponding	O
to	O
all	O
valid	O
correlation	O
estimations	O
;	O
and	O
(	O
2	O
)	O
the	O
Wilcoxon	O
ranksum	O
test	O
of	O
correlations	O
between	O
cancer	B-DS
and	O
non	O
-	O
cancer	B-DS
datasets	O
gives	O
a	O
p	O
-	O
value	O
<=	O
0	O
.	O
01	O
.	O

Identify	O
conditionally	O
activated	O
network	O
module	O
candidates	O

We	O
hierarchically	O
clustered	O
the	O
differentially	O
co	O
-	O
expressed	O
gene	O
pairs	O
based	O
on	O
their	O
expression	O
correlation	O
profiles	O
using	O
the	O
CLUSTER	O
program	O
[	O
55	O
]	O
with	O
complete	O
linkage	O
and	O
Euclidean	O
distance	O
.	O

The	O
Euclidean	O
distance	O
is	O
averaged	O
to	O
provide	O
a	O
simple	O
estimation	O
given	O
the	O
existence	O
of	O
missing	O
correlations	O
(	O
due	O
to	O
the	O
missing	O
value	O
problem	O
).	O
di	O
,	O
j	O
=	O
1c	O
∑	O
k	O
(	O
ri	O
(	O
k	O
)−	O
rj	O
(	O
k	O
))	O
2	O
where	O
ri	O
(	O
k	O
)	O
and	O
rj	O
(	O
k	O
)	O
are	O
the	O
correlations	O
of	O
gene	O
pairs	O
i	O
and	O
j	O
in	O
the	O
dataset	O
k	O
,	O
respectively	O
,	O
and	O
c	O
is	O
number	O
of	O
valid	O
correlations	O
.	O

In	O
the	O
hierarchical	O
tree	O
,	O
each	O
leaf	O
node	O
represents	O
a	O
gene	O
pair	O
,	O
and	O
each	O
inner	O
node	O
corresponds	O
to	O
a	O
second	O
-	O
order	O
cluster	O
of	O
gene	O
pairs	O
(	O
edges	O
)	O
which	O
may	O
comprise	O
zero	O
,	O
one	O
,	O
or	O
more	O
connected	O
network	O
components	O
.	O

In	O
cases	O
where	O
the	O
size	O
of	O
the	O
differential	O
network	O
is	O
too	O
big	O
to	O
be	O
processed	O
using	O
hierarchical	O
clustering	O
(	O
HC	O
),	O
the	O
gene	O
pairs	O
were	O
first	O
separated	O
using	O
k	O
-	O
means	O
clustering	O
then	O
processed	O
the	O
smaller	O
clusters	O
separately	O
by	O
hierarchical	O
clustering	O
.	O

As	O
for	O
our	O
experience	O
,	O
the	O
biologically	O
meaningful	O
modules	O
normally	O
contain	O
less	O
than	O
a	O
few	O
hundred	O
edges	O
,	O
thus	O
k	O
-	O
means	O
clustering	O
will	O
keep	O
most	O
of	O
modules	O
intact	O
.	O

Gene	O
ontology	O
function	O
and	O
transcription	B-GP
factor	I-GP
enrichment	O
of	O
modules	O

The	O
functional	O
enrichment	O
analysis	O
is	O
done	O
by	O
the	O
hypergeometric	O
test	O
on	O
genes	O
.	O

We	O
selected	O
419	O
Gene	O
Ontology	O
(	O
GO	O
)	O
functions	O
(	O
i	O
.	O
e	O
.	O
biological	O
process	O
terms	O
)	O
which	O
are	O
4	O
levels	O
below	O
the	O
root	O
in	O
the	O
GO	O
hierarchy	O
.	O

Each	O
gene	O
may	O
be	O
directly	O
or	O
indirectly	O
associated	O
with	O
some	O
of	O
these	O
functions	O
.	O

A	O
set	O
of	O
genes	O
will	O
be	O
considered	O
to	O
have	O
a	O
enriched	O
function	O
when	O
(	O
1	O
)	O
the	O
functional	O
homogeneity	O
modeled	O
by	O
the	O
hypergeometric	O
distribution	O
[	O
56	O
]	O
is	O
significant	O
at	O
a	O
significance	O
level	O
0	O
.	O
01	O
and	O
(	O
2	O
)	O
there	O
are	O
at	O
least	O
2	O
genes	O
in	O
the	O
set	O
are	O
associated	O
with	O
the	O
function	O
.	O

Identification	O
of	O
transcription	B-GP
factor	I-GP
binding	O

10kb	O
upstream	O
sequences	O
for	O
each	O
gene	O
were	O
obtained	O
from	O
NCBI	O
Gene	O
database	O
.	O

After	O
applying	O
RepeatMasker	O
[	O
57	O
],	O
we	O
used	O
the	O
MATCH	O
program	O
of	O
TRANSFAC	O
[	O
58	O
]	O
(	O
version	O
9	O
.	O
2	O
)	O
to	O
scan	O
the	O
sequences	O
for	O
the	O
presence	O
of	O
transcription	B-GP
factor	I-GP
binding	O
sites	O
based	O
on	O
position	O
weight	O
matrices	O
.	O

We	O
used	O
vertebrate	B-OG
-	O
specific	O
matrices	O
,	O
and	O
chose	O
cut	O
-	O
offs	O
to	O
minimize	O
the	O
sum	O
of	O
false	O
positives	O
and	O
false	O
negatives	O
.	O

We	O
kept	O
only	O
the	O
top	O
3	O
,	O
000	O
hits	O
per	O
matrix	O
,	O
sorted	O
by	O
the	O
matrix	O
similarity	O
score	O
.	O

Altogether	O
we	O
obtained	O
349	O
,	O
178	O
predicted	O
transcription	B-GP
factor	I-GP
target	O
relationships	O
of	O
180	O
transcription	B-GP
factors	I-GP
.	O

A	O
hypergeometric	O
test	O
was	O
performed	O
for	O
each	O
network	O
module	O
to	O
search	O
for	O
over	O
-	O
represented	O
transcription	B-GP
factor	I-GP
binding	O
sites	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

Authors	O
'	O
contributions	O

XJZ	O
conceived	O
the	O
research	O
problem	O
.	O

MX	O
and	O
XJZ	O
designed	O
the	O
methodology	O
.	O

JNI	O
and	O
MW	O
provided	O
suggestions	O
for	O
the	O
design	O
.	O

MX	O
developed	O
programs	O
,	O
collected	O
and	O
processed	O
data	O
.	O

JNI	O
curated	O
data	O
.	O

XJZ	O
,	O
MX	O
and	O
JNI	O
provided	O
general	O
interpretation	O
of	O
results	O
.	O

MJK	O
,	O
XJZ	O
and	O
JNI	O
analyzed	O
specific	O
examples	O
.	O

MX	O
,	O
XJZ	O
,	O
MJK	O
,	O
and	O
JNI	O
drafted	O
the	O
manuscript	O
.	O

JRN	O
commented	O
on	O
the	O
manuscript	O
.	O

MW	O
and	O
JRN	O
suggested	O
more	O
applications	O
of	O
the	O
method	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Supplementary	O
Material	O

Additional	O
file	O
1	O

This	O
document	O
includes	O
1	O
)	O
description	O
of	O
selection	O
of	O
hub	O
genes	O
,	O
2	O
)	O
analysis	O
of	O
functional	O
network	O
homogeneity	O
,	O
3	O
)	O
description	O
of	O
supplementary	O
tables	O
and	O
4	O
)	O
supplementary	O
figures	O
.	O

Click	O
here	O
for	O
file	O

Additional	O
file	O
2	O

Click	O
here	O
for	O
file	O

